Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Reply to comment on the effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy [published online ahead of print June 20, 2025]
A lot of the papers looking at these drugs and their impact on immunity have shown that people who take them respond better to infections, they have better outcomes in the context of fighting different types of cancer, but no one has looked at what is directly happening to the immune cells, says Claire Pillsbury, PhD, a postdoctoral fellow working in the lab of cancer center leader Curtis Henry, PhD
The numbers may be familiar, but they bear repeating: more than 40% of U.S
These side effects are not generally bothersome enough for people to stop the program
